BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting | NEJM<br/><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2101765" rel="noreferrer noopener" target="_blank">nejm.org</a>